Great West Life Assurance CO Otonomy, Inc. Transaction History

Great West Life Assurance CO

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 09, 2018	SELL	$2.8 - $5.55 $13,742 - $27,239	-4,908 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$3.2 - $20.8 $15,705 - $102,086	4,908	4,908 $16,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.